Patients with liver carcinogenesis in c type chronic liver disease who achieved sustained virological response with direct acting antiviral (Daa) treatment

Tomoo Kobayashi, Takehiro Akahane, Yutaka Miyazaki, Teruyuki Umetsu, Tatsuki Morosawa, Osamu Kimura, Futoshi Nagasaki, Mami Kida, Norihiro Kisara, Mitsuru Yamakawa, Noriatsu Kanno, Shu Abe, Yutaka Mano, Toshihiro Satou, Shuuichi Satou, Atsushi Kanno, Masahito Miura

Research output: Contribution to journalArticlepeer-review

Abstract

We examined 1388 patients with chronic liver disease type C without liver cancer history who achieved sustained virological response for 24 weeks or more (SVR24) with direct acting antiviral (DAA) treatment. We assessed the carcinogenic status and investigated liver carcinogenesis predictors. Overall, we identified 39 patients with liver cancer for a cancer rate of 2.8%. We identified the FIB4 index at SVR24 determination as a liver carcinogenesis marker and determined its cutoff value at 3.06. The survival prognosis after achieving SVR was significantly worse in patients with liver carcinogenesis than in those without it. The cumulative risk at 1 year and 6 months after DAA treatment was also higher in patients with liver carcinogenesis (0.055) than in those without it (0.002). The onset of liver cancer is associated with prognosis after achieving SVR; therefore, early detection and treatment of liver cancer are necessary to improve the prognosis of these patients.

Original languageEnglish
Pages (from-to)388-391
Number of pages4
JournalActa Hepatologica Japonica
Volume60
Issue number10
DOIs
Publication statusPublished - 2019 Jan 1
Externally publishedYes

Keywords

  • Direct acting antiviral (DAA)
  • Hepatocarcinogenesis
  • Liver carcinogenesis predictors

ASJC Scopus subject areas

  • Hepatology

Fingerprint Dive into the research topics of 'Patients with liver carcinogenesis in c type chronic liver disease who achieved sustained virological response with direct acting antiviral (Daa) treatment'. Together they form a unique fingerprint.

Cite this